The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
Open accessAbstract
CONTEXT: Data regarding the association between subclinical hypothyroidism and cardiovascular disease outcomes are conflicting among large prospective cohort studies. This might reflect differences in participants' age, sex, thyroid-stimulating hormone (TSH) levels, or preexisting cardiovascular disease. OBJECTIVE: To assess the risks of coronary heart disease (CHD) and total mortality for adults with subclinical hypothyroidism. DATA SOURCES AND STUDY SELECTION: The databases of MEDLINE and EMBASE (1950 to May 31, 2010) were searched without language restrictions for prospective cohort studies with baseline thyroid function and subsequent CHD events, CHD mortality, and total mortality. The reference lists of retrieved articles also were searched. DATA EXTRACTION: Individual data on 55,287 participants with 542,494 person-years of follow-up between 1972 and 2007 were supplied from 11 prospective cohorts in the United States, Europe, Australia, Brazil, and Japan. The risk of CHD events was examined in 25,977 participants from 7 cohorts with available data. Euthyroidism was defined as a TSH level of 0.50 to 4.49 mIU/L. Subclinical hypothyroidism was defined as a TSH level of 4.5 to 19.9 mIU/L with normal thyroxine concentrations. RESULTS: Among 55,287 adults, 3450 had subclinical hypothyroidism (6.2%) and 51,837 had euthyroidism. During follow-up, 9664 participants died (2168 of CHD), and 4470 participants had CHD events (among 7 studies). The risk of CHD events and CHD mortality increased with higher TSH concentrations. In age- and sex-adjusted analyses, the hazard ratio (HR) for CHD events was 1.00 (95% confidence interval [CI], 0.86-1.18) for a TSH level of 4.5 to 6.9 mIU/L (20.3 vs 20.3/1000 person-years for participants with euthyroidism), 1.17 (95% CI, 0.96-1.43) for a TSH level of 7.0 to 9.9 mIU/L (23.8/1000 person-years), and 1.89 (95% CI, 1.28-2.80) for a TSH level of 10 to 19.9 mIU/L (n = 70 events/235; 38.4/1000 person-years; P <.001 for trend). The corresponding HRs for CHD mortality were 1.09 (95% CI, 0.91-1.30; 5.3 vs 4.9/1000 person-years for participants with euthyroidism), 1.42 (95% CI, 1.03-1.95; 6.9/1000 person-years), and 1.58 (95% CI, 1.10-2.27, n = 28 deaths/333; 7.7/1000 person-years; P = .005 for trend). Total mortality was not increased among participants with subclinical hypothyroidism. Results were similar after further adjustment for traditional cardiovascular risk factors. Risks did not significantly differ by age, sex, or preexisting cardiovascular disease. CONCLUSIONS: Subclinical hypothyroidism is associated with an increased risk of CHD events and CHD mortality in those with higher TSH levels, particularly in those with a TSH concentration of 10 mIU/L or greater.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“a recent metaanalysis showed that significantly increased risk of cardiovascular mortality and morbidity was primarily observed in individuals with TSH levels > 10mIU/L, with potential effects of TSH values > 7mIU/L (52).”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [52]
In the citing paper
“Recent individual patient meta-analysis by the Thyroid Studies Collaboration8,9,10,11 did not find higher risk of CVD and all-cause mortality among adults with subclinical hypothyroidism compared with those with euthyroidism”
From Association of subclinical hypothyroidism and cardiovascular disease with mortality (2020) · cites this paper as [8]
In the citing paper
“A previous meta-analysis8 reported that subclinical hypothyroidism is associated with higher CVD risk, and thus treatment with levothyroxine is recommended when serum TSH concentrations reach 10 mIU/L or greater.4,31”
From Association of subclinical hypothyroidism and cardiovascular disease with mortality (2020) · cites this paper as [8]
In the citing paper
“Although epidemiological studies have shown an association between subclinical hypothyroidism and coronary heart disease in younger people (<65 years) 16 or those with high TSH (>10 mU/l), 17”
From Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee (2016) · cites this paper as [17]
In the citing paper
“Similarly, several studies have found an association of elevated serum TSH with adverse cardiac outcomes, including myocardial infarction (MI), heart failure, and mortality (8, 10, 21–24).”
From Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study (2016) · cites this paper as [24]
In the citing paper
“some studies suggest an adverse effect of this state (8, 10, 22, 24) whereas others show a neutral or even protective effect on outcome (2, 17, 25, 29, 36, 37).”
From Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study (2016) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,586
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey
Vanderpump, M. P. J., Tunbrldge, W. M. G., French, J. M., Appleton, D., Bates, D., Clark, F., Evans, J. G., Hasan, D. M., Rodgers, H., Tunbridge, F., et al. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01894.x · Cited by 2,432
Self-citationSystematic Reviews in Health Care : Meta-Analysis in Context
Egger, M., Smith, G. D., & Altman, D. G. (2000) · Cited by 2,312
Thyroid hormone and the cardiovascular system.
Klein, I., & Ojamaa, K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440707 · Cited by 2,300
Fowkes, F. G. R., Murray, G. D., Butcher, I., Heald, C. L., Lee, R. J., Chambless, L. E., Folsom, A. R., Hirsch, A. T., Dramaix, M., DeBacker, G., et al. (2008) · JAMA · doi:10.1001/jama.300.2.197 · Cited by 1,870
Self-citationSubclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA · doi:10.1001/jama.291.2.228 · Cited by 1,800
Self-citationThe Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
Systematic Reviews in Health Care. Meta-analysis in Context.
Kleijnen, J., & Antes, G. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.3.697 · Cited by 1,374
Hak, A. E., Pols, H. A. P., Visser, T. J., Drexhage, H. A., Hofman, A., & Witteman, J. C. M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00004 · Cited by 1,336
Klein, I., & Danzi, S. (2007) · Circulation · doi:10.1161/circulationaha.106.678326 · Cited by 1,324
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259 · cited 3×
“Whickham Survey,17,18 1996, 2010 Adults living in and near Newcastle upon Tyne, England 2406 46 (18-92) 1284 (53.”
BackgroundThyroid Status, Disability and Cognitive Function, and Survival in Old Age
Gussekloo, J. (2004) · JAMA · doi:10.1001/jama.292.21.2591 · Cited by 899
Self-citationThyroid Status, Cardiovascular Risk, and Mortality in Older Adults
Cappola, A. R., Fried, L. P., Arnold, A. M., Danese, M. D., Kuller, L. H., Burke, G. L., Tracy, R. P., & Ladenson, P. W. (2006) · JAMA · doi:10.1001/jama.295.9.1033 · Cited by 862
Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models
Lyles, R. H. (2006) · Journal of the American Statistical Association · doi:10.1198/jasa.2006.s90 · Cited by 784
Regression Methods in Biostatistics
Vittinghoff, E., Glidden, D. V., Shiboski, S. C., & McCulloch, C. E. (2012) · Statistics in the health sciences · doi:10.1007/978-1-4614-1353-0 · Cited by 692
Self-citationParle, J. V., Maisonneuve, P., Sheppard, M. C., Boyle, P., & Franklyn, J. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06067-6 · Cited by 669
Self-citationSimmonds, M. C., Higgins, J. P. T., Stewart, L. A., Tierney, J. F., Clarke, M. J., & Thompson, S. G. (2005) · Clinical Trials · doi:10.1191/1740774505cn087oa · Cited by 554
Subclinical thyroid dysfunction as a risk factor for cardiovascular disease
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O’Leary, P., Leedman, P. J., Feddema, P., & Michelangeli, V. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2467 · Cited by 536
Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death
Rodondi, N., Newman, A. B., Vittinghoff, E., de Rekeneire, N., Satterfield, S., Harris, T. B., & Bauer, D. C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2460 · Cited by 503
Self-citationMeta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality
Ochs, N., Auer, R., Bauer, D. C., Nanchen, D., Gussekloo, J., Cornuz, J., & Rodondi, N. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00225 · Cited by 477
Self-citationStewart, L., & Clarke, M. (1995) · Statistics in Medicine · doi:10.1002/sim.4780141902 · Cited by 465
Meta-analysis of Observational Studies in Epidemiology
Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., Moher, D., Becker, B. J., Sipe, T. A., & Thacker, S. B. (2000) · Cited by 460
Monzani, F., Caraccio, N., Kozàkowà, M., Dardano, A., Vittone, F., Virdis, A., Taddei, S., Palombo, C., & Ferrannini, E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031669 · Cited by 399
A Solution to the Problem of Monotone Likelihood in Cox Regression
Heinze, G., & SCHEMPER, M. (2001) · Biometrics · doi:10.1111/j.0006-341x.2001.00114.x · Cited by 397
Gharib, H., Tuttle, R. M., Baskin, H. J., Fish, L. H., Singer, P. A., & McDermott, M. T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1231 · Cited by 394
Razvi, S., Ingoe, L., Keeka, G., Oates, C., McMillan, C., & Weaver, J. U. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1869 · Cited by 389
Self-citationRisk for Ischemic Heart Disease and All-Cause Mortality in Subclinical Hypothyroidism
Imaizumi, M., Akahoshi, M., Ichimaru, S., Nakashima, E., Hida, A., Soda, M., Usa, T., Ashizawa, K., Yokoyama, N., Maeda, R., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031089 · Cited by 373
Self-citationRazvi, S., Shakoor, A., Vanderpump, M., Weaver, J. U., & Pearce, S. H. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0167 · Cited by 330
Self-citationHelfand, M. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-2-200401200-00015 · Cited by 302
Association between increased mortality and mild thyroid dysfunction in cardiac patients
Iervasi, G. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1526 · Cited by 285
Self-citationSubclinical Thyroid Dysfunction, Cardiac Function, and the Risk of Heart Failure
Rodondi, N., Bauer, D. C., Cappola, A. R., Cornuz, J., Robbins, J., Fried, L. P., Ladenson, P. W., Vittinghoff, E., Gottdiener, J. S., & Newman, A. B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.009 · Cited by 273
Self-citationRazvi, S., Weaver, J. U., Vanderpump, M. P. J., & Pearce, S. H. S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1749 · Cited by 264
Self-citationVanderpump, M. P. J., Tunbridge, W. M. G., French, J. M., Appleton, D. R., Bates, D., Clark, F., Evans, J. G., Rodgers, H., Tunbridge, F. K. E., & Young, E. T. (1996) · PubMed · doi:10.1089/thy.1996.6.155 · Cited by 207
Self-citationThe Use and Misuse of the Sensitive Thyrotropin Assays
NICOLOFF, J. T., & SPENCER, C. A. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-3-553 · Cited by 197
Riley, R. D., Simmonds, M. C., & Look, M. P. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.09.009 · Cited by 196
Surks, M. I., & Ocampo, E. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89462-4 · Cited by 192
Boekholdt, S. M., Titan, S. M., Wiersinga, W. M., Chatterjee, K., Basart, D. C. G., Luben, R., Wareham, N. J., & Khaw, K. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03640.x · Cited by 167
Self-citationSgarbi, J. A., Matsumura, L. K., Kasamatsu, T. S., Ferreira, S. R. G., & Maciel, R. M. B. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0845 · Cited by 138
Self-citationThyrotropin Levels and Risk of Fatal Coronary Heart Disease: The HUNT Study
Åsvold, B. O., Bjøro, T., Nilsen, T. I. L., Gunnell, D., & Vatten, L. J. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.8.855 · Cited by 125
Self-citationVölzke, H., Schwahn, C., Wallaschofski, H., & Dörr, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0179 · Cited by 120
Subclinical Thyroid Dysfunction
Woeber, K. A. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440310023002 · Cited by 107
(2005) · Humana Press eBooks · doi:10.1385/1-59259-944-3:063 · Cited by 56
Thyroid Disease in the Oldest Old
Cooper, D. S. (2004) · JAMA · doi:10.1001/jama.292.21.2651 · Cited by 50
Fatourechi, V., Lankarani, M., Schryver, P. G., Vanness, D. J., Long, K. H., & Klee, G. G. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.5.554 · Cited by 22
Subclinical Thyroid Dysfunction and the Heart
Cappola, A. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1575 · Cited by 15
Self-citationCardiovascular Consequences of Subclinical Thyroid Dysfunction: More Smoke but No Fire
Ladenson, P. W. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00011 · Cited by 14
Subclinical Thyroid Dysfunction
Momotani, N., Itakura, M., Nishizaki, Y., & Ogawa, T. (2004) · Health Evaluation and Promotion · doi:10.7143/jhep.31.482 · Cited by 1
Research works printed but not linked: 10
- [12]Völzke H Schwahn C Wallaschofski H Dörr M Review: the association of thyroid dysfunction with all-cause and circulatory mortality J Clin Endocrinol Metab 2007 92 7 2421 2429 17473067
- [14]Simmonds MC Higgins JP Stewart LA Meta-analysis of individual patient data from randomized trials Clin Trials 2005 2 3 209 217 16279144
- [19]Hollowell JG Staehling NW Flanders WD Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994) J Clin Endocrinol Metab 2002 87 2 489 499 11836274
- [24]Riley RD Simmonds MC Look MP Evidence synthesis combining individual patient data and aggregate data J Clin Epidemiol 2007 60 5 431 439 17419953
- [26]Parle JV Maisonneuve P Sheppard MC Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result Lancet 2001 358 9285 861 865 11567699
- [32]Boekholdt SM Titan SM Wiersinga WM Initial thyroid status and cardiovascular risk factors Clin Endocrinol (Oxf) 2010 72 3 404 410 19486022
- [33]Asvold BO Bjøro T Nilsen TI Gunnell D Vatten LJ Thyrotropin levels and risk of fatal coronary heart disease Arch Intern Med 2008 168 8 855 860 18443261
- [36]Ladenson PW Cardiovascular consequences of subclinical thyroid dysfunction Ann Intern Med 2008 148 11 880 881 18519934
- [40]Monzani F Caraccio N Kozàkowà M Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism J Clin Endocrinol Metab 2004 89 5 2099 2106 15126526
- [41]Vanderpump MP Tunbridge WM French JM The incidence of thyroid disorders in the community Clin Endocrinol (Oxf) 1995 43 1 55 68 7641412
Cited by
Sorted by citations
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
“Although no RCTs are currently available, a recent metaanalysis showed that significantly increased risk of cardiovascular mortality and morbidity was primarily observed in individuals with TSH levels > 10 mIU/L, with potential effects of TSH values > 7 mIU/L (52).”
Self-citationGarber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
Chaker, L., Bianco, A. C., Jonklaas, J., & Peeters, R. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30703-1 · Cited by 1,159
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053
Cooper, D. S., & Biondi, B. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60276-6 · Cited by 1,039
Metadata
- Authors
- Rodondi, N., den Elzen, W. P. J., Bauer, D. C., Cappola, A. R., Razvi, S., Walsh, J. P., Åsvold, B. O., Iervasi, G., Imaizumi, M., Collet, T.-H., Bremner, A., Maisonneuve, P., Sgarbi, J. A., Khaw, K.-T., Vanderpump, M. P. J., Newman, A. B., Cornuz, J., Franklyn, J. A., Westendorp, R. G. J., Vittinghoff, E., Gussekloo, J., & Thyroid Studies Collaboration, F. T.
- Affiliations
- University of Lausanne (CH)
- The University of Western Australia (AU)
- University of Pittsburgh (US)
- Leiden University (NL)
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-09-22
- Volume
- 304
- Issue
- 12
- Pages
- 1365
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC3923470
- OpenAlex
- W2128219988
- Cited by
- 1,216
- References
- 55
- Citations by year
- 2026: 56 · 2025: 53 · 2024: 52 · 2023: 99 · 2022: 94 · 2021: 87 · 2020: 97 · 2019: 77 · 2018: 93 · 2017: 84 · 2016: 74 · 2015: 79 · 2014: 86 · 2013: 69 · 2012: 69
- FWCI
- 43.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Archive ouverte UNIGE (University of Geneva) (acceptedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- IRIS (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Pure Amsterdam UMC (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- UNIFESP Institutional Repository (Universidade Federal de São Paulo) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- U.S. Department of Energy
- American Heart Association (N01-HC-)
- University of Pittsburgh (P30-AG024827)
- Norges Teknisk-Naturvitenskapelige Universitet
- Cancer Research UK
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (911-03-016)
- National Institutes of Health (N01-AG-6-2103, n01hc085082-026, n01hc085081-021, n01ag062101-007, n01hc045133-001, n01hc085079-024, n01hc015103-009, n01hc085084-005, n01cn015103-001, n01ag062103-006, n01hc085085-011, n01hc085083-027, n01hc085080-026, N01‐AG‐6‐2106, n01ag062106-007, n01hc085086-022, N01-AG-6-2101, n01hc075150-004, n01hc035129-010, n01hc055222-001, N01HC85086, AG 20098, N01HC85079, AG-023629, N01-HC-75150, N01HC-35129, N01HC-15103, N01-HC-45133, HL080295)
- Medical Research Council
- Norwegian Institute of Public Health
- National Institute on Aging (N01‐AG‐6–2101, N01-AG-6-2101, N01-AG-6-2103, and N01-AG-6-2106, N01HC85079, N01 HC‐15103, AG 20098, R56AG023629, AG-15928, R01AG032317, N01HC55222, N01‐HC‐35129, N01-HC-75150, R01AG020098, AG023629, N01 AG062106, AG027058, N01AG62106, HL080295, 024827, N01‐HC‐45133, N01‐HC‐85086, R01AG023629, R01AG015928, N01-AG-62103, N01 AG062103, R01AG027058, AG-032317, P30AG024827, N01 AG062101)
- National Heart, Lung, and Blood Institute (N01-HC-85081, N01 HC085086, AG-023629, N01HC-85083, AG-027058, HC-85086, N01HC15103, N01 HC085079, HC85079, N01 HC085083, N01HC85082, N01HC‐75150, N01 HC85086, AG-20098, N01 HC085080, N01 HC035129, HL-075366, N01HC85080, N01-HC, HC-35129, N01AG62101, N01 HC015103, N01HC80007, N01 HC55222, R01HL075366, N01 HC085085, HC-45133, N01‐HC‐45133, N01AG62106, N01HC085082, U01HL080295, N01 HC055222, R01 HL, N01AG62103, AG-15928, N01 HC085081, N01-HC-85079 through N01-HC-85086, HL080295, N01 HC075150, HC-15103, N01 HC085084, N01 HC045133, N01-HC85079, N01HC35129)
- National Cancer Institute (N01 CN015103)
- National Institute of Neurological Disorders and Stroke (N01-AG-6-2106, N01-AG-6-2103, AG023629, AG‐15928, AG‐027058, AG‐20098, N01-HC-75150, HL080295, N01-HC-35129, N01-HC-45133, N01-AG-6-2101, N01-HC-85086, N01 HC-55222, N01HC85079, N01-HC-15103)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- subclinical hypothyroidism, coronary artery disease, cardiovascular mortality, thyroid-stimulating hormone, thyroid function, cardiovascular risk, euthyroidism, prospective cohort, cardiovascular outcomes, sex differences, age differences, cardiovascular risk factors, cardiovascular screening, cardiovascular disease prevention
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Coronary Disease, Female, Humans, Hypothyroidism, Male, Middle Aged, Mortality, Prospective Studies, Risk, Thyrotropin, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
